Now showing items 1-6 of 6

    • Cost-effectiveness analysis of preoperative treatment of acromegaly with somatostatin analogue on surgical outcome 

      Margusino-Framiñán, Luis; Pértega-Díaz, Sonia; Pena-Bello, Lara; Sangiao-Alvarellos, Susana; Outeiriño-Blanco, Elena; Pita-Gutiérrez, Francisco; Pita-Fernández, Salvador; Cordido, Fernando (Elsevier, 2015-08-20)
      [Abstract] Context. There is no uniform standard of care for acromegaly. Due to the high costs involved, steps must be taken to ensure the cost-effective delivery of treatment. Objective. Taking the results of an earlier ...
    • Effectiveness of lanreotide autogel 120 mg at extended dosing intervals for acromegaly 

      Bernabéu, Ignacio; Fajardo, Carmen; Marazuela, Mónica; Cordido, Fernando; Venegas, Eva; Pablos Velasco, Pedro de; Piedrola Maroto, Gonzalo; Olvera Márquez, María del Pilar; Pavón de Paz, Isabel; Carvalho, Davide; Romero, Carmen; De la Cruz, Guillermo; Álvarez Escolá, Cristina (Springer, 2020-07-28)
      [Abstract] Purpose. Recent data indicate that extended dosing intervals (EDIs) with lanreotide autogel 120 mg are effective and well-received among patients with acromegaly who have achieved biochemical control with monthly ...
    • Factors associated with therapeutic response in acromegaly diagnosed in the elderly in Spain 

      Biagetti, Betina; Iglesias, Pedro; Villar-Taibo, Rocío; Moure, María-Dolores; Paja, Miguel; Araújo-Castro, Marta; Ares, Jessica; Álvarez-Escola, Cristina; Vicente, Almudena; Álvarez Guivernau, Élia; Novoa-Testa, Iria; Guerrero Pérez, Fernando; Cámara, Rosa; Lecumberri, Beatriz; García Gómez, Carlos; Bernabéu, Ignacio; Manjón, Laura; Gaztambide, Sonia; Cordido, Fernando; Webb, Susan; Webb, Susan M.; Menéndez-Torre, Edelmiro Luis; Díez, Juan J.; Simó, Rafael; Puig-Domingo, Manel (Frontiers, 2022-09-16)
      [Abstract] Context: Some reports suggest that acromegaly in elderly patients has a more benign clinical behavior and could have a better response to first-generation long-acting somatostatin receptor ligands (SRL). However, ...
    • Pituitary MRI features in acromegaly resulting from ectopic GHRH secretion from a neuroendocrine tumor: analysis of 30 cases 

      Potorac, Iulia; Bonneville, Jean-François; Daly, Adrian F.; de Herder, Wouter; Fainstein-Day, Patricia; Chanson, Philippe; Korbonits, Marta; Cordido, Fernando; Lamback, Elisa Baranski; Abid, Mohamed; Raverot, Véronique; Raverot, Gerald; Anda Apiñániz, Emma; Caron, Philippe; Du Boullay, Helene; Bidlingmaier, Martin; Bolanowski, Marek; Laloi-Michelin, Marie; Borson-Chazot, Francoise; Chabre, Olivier; Christin-Maitre, Sophie; Briet, Claire; Díaz-Soto, Gonzalo; Bonneville, Fabrice; Castinetti, Frederic; Gadelha, Mônica R.; Oliveira Santana, Nathalie; Stelmachowska-Banaś, Maria; Gudbjartsson, Tomas; Villar-Taibo, Rocío; Zornitzki, Taiba; Tshibanda, Luaba; Petrossians, Patrick; Beckers, Albert (Oxford University Press on behalf of the Endocrine Society, 2022-05-04)
      [Abstract] Context: Ectopic acromegaly is a consequence of rare neuroendocrine tumors (NETs) that secrete GHRH. This abnormal GHRH secretion drives GH and IGF-1 excess, with a clinical presentation similar to classical ...
    • Practical guidelines for diagnosis and treatment of acromegaly 

      Cordido, Fernando; García-Arnés, Juan Antonio; Marazuela, Mónica; Torres Vela, Elena (Elsevier, 2013-10)
      [Abstract] Acromegaly and gigantism are due to excess GH secretion, usually by a pituitary adenoma. It is an uncommon disease. Diagnosis is made by showing elevated GH and IGF-I levels in patients with a clinical picture ...
    • Treatment adherence to pegvisomant in patients with acromegaly in Spain: PEGASO study 

      Cámara, Rosa; Venegas, Eva; García-Arnés, Juan Antonio; Cordido, Fernando; Aller, J.; Samaniego, M. Luz; Mir, Nuria; Sánchez-Cenizo, Laura (Springer, 2019-02-13)
      [Abstract] PURPOSE: The burden of chronic daily subcutaneous administration of pegvisomant on adherence has not been previously studied. This study was aimed to determine the adherence to pegvisomant treatment in acromegaly ...